Journal
CANCER TREATMENT REVIEWS
Volume 94, Issue -, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ctrv.2021.102158
Keywords
Breast cancer; Breast MRI; Ductal carcinoma in situ; Surgery; Oncoplastic; Mastectomy
Categories
Funding
- NIHR Cambridge Biomedical Research Centre
Ask authors/readers for more resources
The utility of MRI in predicting tumor size accurately in DCIS patients is noted, with no significant difference in surgical outcomes between pre-operative MRI and conventional imaging groups. However, there is a lack of data on the usefulness of pre-operative MRI in oncoplastic breast surgery.
The impact of MRI on improving surgical outcomes in DCIS is debated. Here, we explore the utility of MRI in the investigation and management of DCIS in three key areas. Firstly, we highlight that MRI is likely to be a more accurate predictor of actual tumour size than conventional imaging. Secondly, we examine mastectomy rates and reoperation rates across the literature and suggest that surgical outcomes do not differ between pre-operative MRI and conventional imaging groups, despite improved size estimation on MRI. Finally, we examine the rapidly developing field of oncoplastic breast surgery and highlight a paucity of data in determining the usefulness of pre-operative MRI in this field, despite this being an oncologically safe alternative with improved patient outcomes and satisfaction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available